Volume 6, Issue 3 (17 2007)                   ijdld 2007, 6(3): 301-307 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Valikhani M, Khoshniat Niko M, Naser Tork A. RISK FACTORS AND FREQUENCY OF STEROID - INDUCED DIABETES IN PEMPHIGUS VULGARIS PATIENTS DURING 1 YEAR STUDY. ijdld 2007; 6 (3) :301-307
URL: http://ijdld.tums.ac.ir/article-1-322-en.html
Abstract:   (10838 Views)

Background:  Pemphigus vulgaris is the most common autoimmune blistering disease. Corticosteroid is treatment of choice for it. Medication can affect many organs and causes metabolic difficulties which steroid- induced diabetes (SID) is one of the most important side effects. Determining risk factors not only help identify diabetes in early stages but also let continuing treatment of underlying disease.                                                

Methods:  Sixty eight patients with recently diagnosed pemphigus vulgaris were recruited. After admitting in hospital they were evaluated for positive family history of diabetes, blood pressure, body mass index (BMI), FBS, HbA1c, TG and HDL. Then they followed with FBS twice per week for 8 weeks.       

Results: Ninety patients (27.9%) developed diabetes. In comparison with non-diabetic group, diabetic group had a significantly higher   HbA1c>6% (NL: 4.5-6.8) or: 8.39 (CI: 1.46- 48.05), TG > = 200 or: 6.56 (CI: 1.64-28.18) and IFG or: 3.11 (CI: 1.04-9.31). There were no differences between the groups in respect of age, positive family history, blood pressure, BMI, HDL.

Conclusion: These findings suggest that HbA1c,TG and IFG are independent risk factors so patients with pemphigus vulgris who are candidates for steroid treatment should be evaluated for HbA1c, TG and IFG before  treatment.                                                    

Full-Text [PDF 213 kb]   (3036 Downloads)    
Type of Study: Research | Subject: General
Received: 2007/04/7 | Accepted: 2007/05/17 | Published: 2013/10/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by: Yektaweb